p53/PD-L1 co-expression predicts poor prognosis in diffuse large B-cell lymphoma

p53/PD-L1 co-expression predicts poor prognosis in diffuse large B-cell lymphoma

Abstract Objective To investigate the clinical characteristics and survival of p53 and Programmed death-ligand 1 (PD-L1) co-expression in diffuse large B-cell lymphoma (DLBCL) patients. Methods Immunohistochemistry (IHC) was used to detect the expression of p53 and PD-L1 in tumor cells of 176 patien...

Full description

Saved in:
Bibliographic Details
Main Authors: Yaoyao Jing, Ying Yuan, Yong Yu, Haifeng Zhao, Hongliang Yang, Xiaofang Wang
Format: Article
Language:English
Published: Springer 2025-07-01
Series:Discover Oncology
Subjects:
p53/PD-L1 co-expression
p53
PD-L1
Diffuse large B-cell lymphoma
Prognosis
Rituximab
Online Access:https://doi.org/10.1007/s12672-025-03062-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s12672-025-03062-5

Similar Items